This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Maddux FW, Shetty S, Del Aguila MA, Nelson MA, Murray BM.Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease. Annals of Pharmacotherapy 41: 1761-1769, No. 11, Nov 2007
Rights and permissions
About this article
Cite this article
ESA treatment lowers overall costs in CKD-related anaemia. Pharmacoecon. Outcomes News 539, 9 (2007). https://doi.org/10.2165/00151234-200705390-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705390-00020